Knockout of ADAMTS1 in mammary and melanoma cancer models resulted in reduced primary and secondary tumor burden, which correlated with increased infiltration of cytotoxic lymphocytes and increased expression of genes involved in antitumor immune reactions [133,134]. Here, ADAMTS1 is linked to neoplasm.